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Introduction 
Epidermal nevi (EN) are hamartomas characterized 
by hyperplasia of any part of the epidermis, including 
adnexal structures. Linear verrucous epidermal 
nevus (LVEN) originates from keratinocyte 
hyperplasia, and they are clinically characterized by 
skin-colored or brown papules and/or plaques, with 
a verrucous surface, appearing linearly, following the 
lines of Blaschko [1, 2]. Although the etiology is not 
completely understood, it seems that this is a mosaic 
disorder resulting from a postzygotic mutation [3, 4]. 
Oral involvement of LVEN is very rare and only a few 
cases have been reported in the scientific literature.  
We report two new cases of LVEN affecting the face 
with oral manifestations. 
 
Case Synopsis 
Case 1 
A 9-year-old boy was referred to our clinic with a 
widespread plaque affecting the right side of his 
face, chin, neck, and oral cavity. His parents recalled 
the first appearance of lesions at birth. It initially 
presented as hyperpigmented linear streaks on his 
right cheek, which gradually increased in size and 
thickness and became more elevated and verrucous. 
The plaques followed the lines of Blaschko stopping 
abruptly at the midline on his chin. He also had a 
similar solitary plaque on the midline of his anterior 
neck. He had intraoral verrucous lesions inside his 
lower lip and at the right buccal mucosa (Figure 1). 
This patient was otherwise healthy and his eye, 
orthopedic, and neurological examinations were 
unremarkable. 
Case 2 
An 8-year-old girl presented with a large, dark-brown 
verrucous plaque with a linear pattern of distribution 
on the left side of her face that extended from the 
scalp and forehead to the neck following the lines of 
Blaschko. The parents recalled the first appearance of 
the lesion when she was born and noticed that it was 
gradually increasing in size and pigmentation. 
Intraorally, she had a verrucous plaque with a pink, 
papillary surface that was located on the left side of 
her hard and soft palate area, upper and lower lips, 
buccal mucosa, and gingiva (Figure 2). She was in 
Abstract 
Linear verrucous epidermal nevi (LVEN) are 
characterized by verrucous papules often coalescing 
into well-demarcated skin-colored or brown plaques 
following the lines of Blaschko. We present two new 
cases of LVEN with oral mucosa involvement and 
briefly discuss this very rare finding. In both cases, 
oral biopsies showed hyperkeratosis, acanthosis, and 
papillomatosis. Although several treatment 
modalities have been reported for the cutaneous 
lesions, there is no consensus for the management of 
oral lesions so far. 
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good health and had no ocular, skeletal, or 
neurologic abnormalities. 
An informed consent was obtained from the parents 
and the patients prior to clinical evaluation as part of 
an internal protocol of our institution. After informed 
consent of patients and parents, intraoral lesions 
were biopsied. On histological examination, both 
biopsies showed a papillomatous surface with 
hyperkeratosis and acanthosis, typical of epidermal 
nevi. In both cases, elongated rete ridges and an 
increase in melanin in the basal cell layer were 
observed (Figures 1 and 2). In both current cases, 
patients and parents did not accept any treatment 
modality. Clinical follow-up twice a year was 
suggested for both patients. 
 
Case Discussion 
Epidermal nevi are defined according to the 
predominant cell type: predominance of 
keratinocytes (verrucous epidermal nevus), 
sebaceous glands (nevus sebaceous), pilosebaceous 
units (nevus comedonicus), sweat glands (apocrine 
and eccrine nevus), and mucosal epithelium (white 
sponge nevus), [5]. 
Verrucous epidermal nevus is the most common 
type of epidermal nevus and it is characterized by 
verrucous papules that coalesce to form well-
demarcated papillomatous plaques that are skin-
colored-to-brown. These hamartomas can be 
located anywhere in the body, including the head, 
trunk, or extremities. They are usually present at birth 
or infancy and may enlarge slowly during childhood 
and adolescence [6]. When these lesions are linear in 
appearance following the lines of Blaschko — with 
streaks and whorls stopping abruptly at the midline 
— they are known as LVEN [1, 5, 7]. 
The prevalence of epidermal nevi is 0.1 to 0.5% and 
there is no predilection for gender or race [2]. The 
incidence of all types of epidermal nevi is estimated 
to be one in 1000 live births. Most lesions arise 
 
Figure 1. A) Hyperpigmented verrucous linear plaques end abruptly at the midline. B, C) Pink verrucous lesions inside his lower lip and 
at the right buccal mucosa. D) Oral biopsy revealed hyperkeratosis, acanthosis, and papillomatosis. H&E, 200×. 
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sporadically during the embryonic development 
phase, but familial patterns of inheritance have been 
observed [5]. 
Mosaicism can originate by different mechanisms, 
but genetic mutation is an essential step that occurs 
during embryogenesis [3, 6, 8]. A mosaic can be 
understood as an individual with two or more 
genetically distinct cell populations derived from a 
genetically homogeneous zygote [4]. 
The prototype for patterns of cutaneous mosaicism 
is exhibited by the lines of Blaschko and they 
represent the development and migration of the 
ectoderm. As the growth of the embryo progresses, 
cells start to proliferate at the midline and grow in a 
V shape on the back and an S shape on the 
anterolateral portion of the trunk. On the face they 
display an hourglass-like arrangement converging 
on the nasal root. On the scalp they form a spiral 
configuration. In LVEN, only a group of ectodermal 
cells carry the genetic alterations that will clinically 
manifest as cutaneous whorls and swirls [4, 9]. 
The histopathologic features of both oral and 
cutaneous LVEN include hyperkeratosis, acanthosis, 
and papillomatosis. The rete ridges are elongated 
and focal thickening of the granular layer might be 
seen. Occasionally, an increase in melanin in the 
basal cell layer is evident. Granular degeneration of 
the epidermis can be visualized and is marked by 
perinuclear vacuolization of the cells. Additionally, 
the lesion margins are sharply demarcated from the 
surrounding normal epithelium on microscopic 
examination [9, 10]. Lesions can also be 
subcategorized as into epidermolytic and non-
epidermolytic [2]. Recent reports in the literature 
point to a relation between the disease with the 
fibroblast growth factor receptor 3 gene (FGFR3) and 
the phosphatidylinositol 3-kinase catalytic subunit 
alpha (PIK3CA) oncogene [2, 11]. 
Epidermal nevus syndromes (ENS) are defined as the 
presence of epidermal nevi associated with 
involvement of other organ systems [4, 12]. When 
lesions are extensive, a work-up for ENS is indicated 
and should include evaluations for ocular, skeletal, 
neurologic, and other internal developmental 
 
 
 
 
Figure 2. A) Dark-brown verrucous plaque following the lines of 
Blaschko extending from the scalp and forehead to the neck. (B, 
C) Pink verrucous plaques on the hard and soft palates, gingiva, 
upper and lower lips, and buccal mucosa. D) Histopathologic 
study of oral specimen showed hyperkeratosis, acanthosis with 
elongation of the rete ridges, and papillomatosis. H&E, 100×. 
A 
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defects. In a review of 131 cases of epidermal nevi, it 
was found that 33% of patients had ENS [12]. 
The vast majority of ENS are not associated with 
malignancy. In very rare cases, especially for 
sebaceous nevus, it is possible the occurrence of 
basal cell carcinomas, keratoacanthomas, 
spinocellular carcinomas, and malignant eccrine 
poromas [3]. Malignant change should be raised 
when lesions exhibit sudden localized growth or 
ulceration [9]. To date, there have been no reports of 
oral lesions of LVEN that have undergone malignant 
transformation.  
Oral involvement of LVEN is an uncommon finding 
and the diagnosis of LVEN exclusively limited to the 
oral cavity is very rare. Lesions are often 
characterized by localized pink verrucous growths 
with well-defined borders on the lips, palate, gingiva, 
buccal mucosa, and tongue. Less common findings 
include tongue hypertrophy, dental anomalies, and 
high arched palate [7, 9, 13]. Oral lesions of LVEN can 
affect different anatomical sites but they do not cross 
the midline. This observation suggests that the oral 
cavity might have a pattern of distribution of the 
lines of Blaschko similar to the skin [1]. 
The main entities in the clinical differential diagnosis 
for intraoral LVEN lesions include human 
papillomavirus-related lesions (squamous 
papillomas, condyloma, verruca vulgaris, focal 
epithelial hyperplasia), lymphangioma, and 
verrucous carcinoma for lesions observed in adults. 
The diagnosis is mainly made according to the 
histopathological findings [7, 9]. 
The treatment of LVEN is challenging and many 
different therapeutic modalities have been 
attempted with variable results. Considering the 
rarity of LVEN with oral involvement, no definitive 
treatment guideline is currently available for oral 
lesions [1]. 
Treatment of cutaneous lesions of LVEN consists of 
surgical excision extending into the deep dermis to 
avoid recurrence. However, surgical removal may 
not be possible owing to extensive involvement. 
Other destructive methods including 
electrofulguration, cryosurgery, and dermabrasion 
may be effective, but also tend to produce scarring 
[14]. 
Topical agents (calcipotriol, steroids, 5-fluorouracil, 
podophyllin, and retinoic acid) have usually been 
ineffective with high recurrence rates [2]. Success 
with the antipsoriatic agents (isotretinoin, 
anthralin, and topical calcipotriol) has been reported 
in treating the inflammatory variant of LVEN, also 
known as ILVEN, suggesting that this condition 
represents a linear psoriasis or superimposed 
psoriasis [5]. 
The use of lasers in treating epidermal nevi has been 
reported, but successful eradication appears 
dependent on the clinical characteristics of the 
nevus. Softer, flat nevi seem to be more responsive 
than firm, keratotic forms [5, 15]. Er:YAG laser 
ablation has a comparable clinical improvement with 
CO2 laser, but the rate of recurrence is higher with 
Er:YAG laser [14]. 
Patients and caregivers should understand that the 
lesions can recur after non-surgical procedures and if 
the involvement is extensive the clinician should 
consider a conservative approach. 
 
Conclusion 
Linear verrucous epidermal nevus is a sporadic 
hamartomatous condition of the skin and/or 
mucosal tissue owing to the proliferation of clonal 
ectodermal cells, which are arranged following the 
lines of Blaschko. Clinically, they are seen as skin-
colored or brown papules, nodules, or plaques with 
a verrucous surface. These lesions are unilateral and 
characteristically they do not cross the midline. Oral 
involvement is a rare manifestation and when it 
occurs, it can be seen on the lips, tongue, buccal 
mucosa, hard and soft palate, and gingiva. 
Histologically, LVEN shows hyperkeratosis, 
acanthosis, and papillomatosis. 
The treatment of cutaneous LVEN is difficult and 
includes surgical excision, electrofulguration, 
cryosurgery, and dermabrasion, with an important 
risk of scarring. Topical agents have been suggested, 
such as calcipotriol, corticosteroids, 5-fluorouracil, 
podophyllin, and retinoic acid, but recurrence is  
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expected when the medication is discontinued. 
Ablative lasers are also a possibility for the 
management of this condition. Since oral lesions are 
extremely rare, uncertainty remains regarding the 
most effective therapeutic modalities. Further  
studies need to be carried out in order to evaluate 
how mucosal lesions should be managed. 
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